Comparison of IFN-alpha 2b with or without ribavirin for treatment of chronic hepatitis C in HIV-positive patients infected with hepatitis C virus genotype 3a

AIDS. 2004 Apr 30;18(7):1080-2. doi: 10.1097/00002030-200404300-00022.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications*
  • Hepacivirus / classification*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Recombinant Proteins
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin